[1] |
BERGAU L, BENGEL P, SCIACCA V, et al. Atrial fibrillation and heart failure[J]. J Clin Med, 2022, 11(9):2510.
|
[2] |
KARNIK A A, GOPAL D M, KO D, et al. Epidemiology of atrial fibrillation and heart failure: a growing and important problem[J]. Cardiol Clin, 2019, 37(2):119-129.
doi: S0733-8651(19)30001-3
pmid: 30926013
|
[3] |
ARIYARATNAM J P, LAU D H, SANDERS P, et al. Atrial fibrillation and heart failure: epidemiology, pathophysiology, prognosis, and management[J]. Card Electrophysiol Clin, 2021, 13(1):47-62.
doi: 10.1016/j.ccep.2020.11.004
pmid: 33516407
|
[4] |
CHANG H Y, FENG A N, FONG M C, et al. Managements and outcomes of hospitalized heart failure patients with paroxysmal vs nonparoxysmal atrial fibrillation in Taiwan[J]. J Chin Med Assoc, 2019, 82(5):356-362.
|
[5] |
WERHAHN S M, BECKER C, MENDE M, et al. NT-proBNP as a marker for atrial fibrillation and heart fai-lure in four observational outpatient trials[J]. ESC Heart Fail, 2022, 9(1):100-109.
|
[6] |
CHOUAIRI F, PACOR J, MILLER P E, et al. Effects of atrial fibrillation on heart failure outcomes and NT-proBNP levels in the GUIDE-IT trial[J]. Mayo Clin Proc Innov Qual Outcomes, 2021, 5(2):447-455.
doi: 10.1016/j.mayocpiqo.2021.02.005
pmid: 33997640
|
[7] |
BRADY P F, CHUA W, NEHAJ F, et al. Interactions between atrial fibrillation and natriuretic peptide in predicting heart failure hospitalization or cardiovascular death[J]. J Am Heart Assoc, 2022, 11(4):e022833.
|
[8] |
ZĂGREANU V M, POP D, ZDRENGHEA M, et al. Plasmatic levels of N-terminal pro-BNP in elderly patients with atrial fibrillation and heart failure with preserved ejection fraction[J]. Iran J Public Health, 2017, 46(4):568-570.
pmid: 28540276
|
[9] |
KIUCHI K, SHIRAKABE A, KOBAYASHI N, et al. Prognostic impact of new-onset atrial fibrillation associated with worsening heart failure in aging patients with severely decompensated acute heart failure[J]. Int J Cardiol, 2020, 302:88-94.
doi: S0167-5273(19)33225-5
pmid: 31813678
|
[10] |
NAGUEH S F, MIDDLEERON K J, KOPELEN H A, et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressure[J]. J Am Coll Cardiol, 1997, 30(6):1527-1533.
|
[11] |
BELTRAMI M, DEI L L, MILLI M. The role of the left atrium: from multimodality imaging to clinical practice: a review[J]. Life (Basel), 2022, 12(8):1191.
|
[12] |
TSUCHIDA K, TANABE K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion[J]. J Cardiol, 2004, 44(1):1-11.
pmid: 15334879
|
[13] |
INOUE N, ISHIKAWA T, SUMITA S, et al. Suppression of atrial fibrillation by atrial pacing[J]. Circ J, 2006, 70(11):1398-1401.
pmid: 17062960
|
[14] |
高艳, 刘悦, 叶斌. 年龄 房颤 舒张压对急性缺血性脑卒中rt-PA静脉溶栓后出血转化的影响[J]. 安徽医学, 2023, 44(3):245-251.
|
|
GAO Y, LIU Y, YE B. Influence of age atrial fibrillation and diastolic pressure on hemorrhage transformation after intravenous thrombolysis with RT-PA in acute ischemic stroke[J]. Anhui Med, 2023, 44(3):245-251.
|
[15] |
鲁锋, 侯杰, 李宝同, 等. 乳脂球表皮生长因子-8在心房颤动中的临床应用[J]. 中国临床研究, 2023, 36(2):263-265,270.
|
|
LU F, HOU J, LI B T, et al. Clinical application of milk fat globule-epidermal growth factor 8 in atrial fibrillation[J]. Chin J Clin Res, 2023, 36(2):263-270.
|
[16] |
蒲振业, 李鸿雁, 何伟, 等. 不停跳冠状动脉旁路移植术后发生房颤的影响因素[J]. 中国临床研究, 2022, 35(8):1055-1058.
|
|
PU Z Y, LI H Y, HE W, et al. Influencing factors of atrial fibrillation after off-pump coronary artery bypass grafting[J]. Chin J Clin Res, 2022, 35(8):1055-1058.
|